Click Here to return To Results

 

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain NEJM 379:722-730,789, Tawbi, H.A.,et al, 2018 See this aricle in Pubmed Article Abstract Nivolumab combined with ipilimumab had clinically meaningful intracranial efficacy, concordant with extracranial activity, in patients with melanoma who had untreated brain metastases.

Related Tags

(click to filter results - removes previous filter) efficacy immune checkpoint inhibitors immunotherapy ipilimumab melanoma,malignant neoplasm,metastatic to CNS neoplasm,metastatic to CNS-treatment of nivolumab safety treatment of neurologic disorder

Click Here to return To Results